TORONTO, July 3, 2019 /CNW/ - Kevin Sullivan, Chief Executive Officer, Appili Therapeutics Inc. (APLI), joined Tim Babcock, Managing Director, Capital Formation, TSX Venture Exchange, to open the market. Headquartered in Halifax, Nova Scotia, Appili is a biopharmaceutical company focused on the acquisition and development of novel treatments targeting unmet needs in infectious disease. Appili Therapeutics Inc. commenced trading on TSX Venture Exchange on June 25, 2019.

Appili Therapeutics Inc. Opens the Market (CNW Group/TMX Group Limited)

SOURCE TMX Group Limited

Copyright 2019 Canada NewsWire

Appili Therapeutics (TSXV:APLI)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Appili Therapeutics Charts.
Appili Therapeutics (TSXV:APLI)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Appili Therapeutics Charts.